首頁 › 瀰漫性大B細胞淋巴瘤 › 內布拉斯加 › Omaha
Omaha, NE 的 瀰漫性大B細胞淋巴瘤 臨床試驗
9 項針對 瀰漫性大B細胞淋巴瘤 的研究正在 Omaha（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
招募中2 期
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 距離 9 英里
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
招募中2/3 期
- Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
招募中2 期
- University Of Nebraska Medical Center ( Site 0110), Omaha
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
招募中1 期
- The University of Nebraska Medical Center, Omaha
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
招募中2 期
- Nebraska Cancer Specialists, Omaha
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- University of Nebraska Medical Center, Omaha
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- University of Nebraska Medical Center (UNMC), Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
招募中1/2 期
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
招募中2 期
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
其他城市的 瀰漫性大B細胞淋巴瘤 試驗
- New York City, NY21 項研究
- Baldwin Park, CA19 項研究
- Chicago, IL18 項研究
- Houston, TX17 項研究
- Los Angeles, CA17 項研究
- Boston, MA16 項研究
- Milwaukee, WI16 項研究
- Nashville, TN15 項研究
- Portland, OR15 項研究
- Philadelphia, PA15 項研究
- Durham, NC14 項研究
- Dallas, TX13 項研究
Omaha 的其他研究
- 前列腺癌27 項研究
- 非小細胞肺癌24 項研究
- 乳癌22 項研究
- 大腸直腸癌18 項研究
- 癌症（所有類型）18 項研究
- 多發性骨髓瘤16 項研究
- 非霍奇金淋巴瘤14 項研究
- 卵巢癌14 項研究
- 胰臟癌14 項研究
- 頭頸部鱗狀細胞癌13 項研究
- 心臟衰竭13 項研究
- 轉移性癌症13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。